2013
A stylish, in-depth look at the renaissance in psychedelic drug research in light of current scientific, medical, and cultural knowledge.
85 min
CLEAR ALL
Like most people of color in the United States, psychotherapist and researcher Monnica Williams has experienced myriad forms of racism. Early in her career, understanding its effects on her mind and body motivated her to help clients address their own racial trauma in therapy.
We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.
These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.
2
Recently, there has been much excitement in the potential of psychedelic-assisted psychotherapy to address a multitude of mental health conditions, including depression, posttraumatic stress disorder, addiction, end-of-life anxiety, and others. However, not everyone has been included.
Dr. Monnica Williams is a professor, clinical psychologist, and the Canada Research Chair for Mental Health Disparities at the University of Ottawa.
In this timely webinar - moderated by Chief Psychologist (USA) Dr. Dominique Morisano - clinical psychologist and thought-leader Dr.